- Home
- COEP vs LCFY Comparison
COEP vs LCFY Comparison
Compare COEP & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- LCFY
- Stock Information
- Founded
- COEP 2017
- LCFY 2009
- Country
- COEP United States
- LCFY Australia
- Employees
- COEP N/A
- LCFY N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- LCFY
- Sector
- COEP Health Care
- LCFY
- Exchange
- COEP Nasdaq
- LCFY Nasdaq
- Market Cap
- COEP 8.1M
- LCFY 7.3M
- IPO Year
- COEP N/A
- LCFY 2022
- Fundamental
- Price
- COEP $0.21
- LCFY $6.30
- Analyst Decision
- COEP
- LCFY
- Analyst Count
- COEP 0
- LCFY 0
- Target Price
- COEP N/A
- LCFY N/A
- AVG Volume (30 Days)
- COEP 282.8K
- LCFY 19.2K
- Earning Date
- COEP 11-13-2024
- LCFY 11-12-2024
- Dividend Yield
- COEP N/A
- LCFY N/A
- EPS Growth
- COEP N/A
- LCFY N/A
- EPS
- COEP N/A
- LCFY N/A
- Revenue
- COEP N/A
- LCFY $3,169,582.00
- Revenue This Year
- COEP N/A
- LCFY N/A
- Revenue Next Year
- COEP N/A
- LCFY N/A
- P/E Ratio
- COEP N/A
- LCFY N/A
- Revenue Growth
- COEP N/A
- LCFY N/A
- 52 Week Low
- COEP $0.15
- LCFY $2.20
- 52 Week High
- COEP $1.33
- LCFY $11.23
- Technical
- Relative Strength Index (RSI)
- COEP 50.31
- LCFY 63.67
- Support Level
- COEP $0.19
- LCFY $5.54
- Resistance Level
- COEP $0.22
- LCFY $7.99
- Average True Range (ATR)
- COEP 0.02
- LCFY 0.39
- MACD
- COEP -0.00
- LCFY 0.17
- Stochastic Oscillator
- COEP 46.15
- LCFY 61.62
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.